e-commentary

. . .

J          “My body, my choice.  Your body, my choice.  His body, my choice.  Her body, my choice.  Their body, my choice.  I am the government; my choice.”

K          “My body, my choice.  Your body, your choice.  His body, his choice.  Her body, her choice.  Their body, their choice.  I am my, you are your, he is his, she is her and they are their.  I should be the government allowing citizens to be citizens.”

. . .

K          “My libertarian progressive friends are incapacitated by fear and retreated from reasonable libertarianism to frightened authoritarianism and totalitarianism.”

J          “My libertarian progressive friends recognize that at times the common weal and the public good require collective interests to trump individual concerns.”

. . .

K          “If the rallying cry for bodily sovereignty relates only to some parts or systems or situations, we are in a world of hurt.”

. . .

[See “The Secret of Propaganda: Teaching Obedience” in “The Seneca Effect” dated January 23, 2022 by Ugo Bardi.]

Bumper stickers of the week:

“Don’t cling to a mistake just because you spent a lot of time making it.”  Unknown

“The cost of sanity in this society is a certain level of alienation.”  Terrence McKenna.

“This proposal from the three fringe epidemiologists [Dr. Martin Kulldorf of Harvard, Dr. Jay Bhattacharya of Stanford and Dr. Sunetra Gupta of Oxford] who met with the Secretary seems to be getting a lot of attention – and even a co-signature from Nobel Prize winner Mike Leavitt [a biophysicist and professor of structural biology at Stanford University and recipient of the 2013 Nobel Prize in chemistry] at Stanford.  There needs to be a quick and devastating published takedown of its premises.  I don’t see anything like that online yet – is it underway?”  Francis Collins, retired hit man at the NIH (emphasis added).

This entry was posted on February 7, 2022 at 10:37 pm and is filed under Authoritarianism, Covid / Coronavirus, Totalitarianism. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.